When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FDA action approving narsoplimab in treatment of HSCT-TMA in Omeros' upcoming PDUFA date has the potential to vault Omeros into multibagger territory overnight.
Omeros' narsoplimab in treatment of severely ill COVID-19 patients presents an interesting opportunity.
Omeros' long struggles over the years have not gone unnoticed by short sellers creating potential for share price ructions.